BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 2406682)

  • 21. Clonality of slime-producing methicillin-resistant coagulase-negative staphylococci disseminated in the neonatal intensive care unit of a university hospital.
    Foka A; Chini V; Petinaki E; Kolonitsiou F; Anastassiou ED; Dimitracopoulos G; Spiliopoulou I
    Clin Microbiol Infect; 2006 Dec; 12(12):1230-3. PubMed ID: 17121632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coagulase-negative staphylococcal infections].
    Kobayashi H
    Nihon Rinsho; 1992 Nov; 50(11):2765-72. PubMed ID: 1287251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulase-negative staphylococci. Epidemiology, evaluation, and therapy.
    Nafziger DA; Wenzel RP
    Infect Dis Clin North Am; 1989 Dec; 3(4):915-29. PubMed ID: 2687369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of staphylococci isolated fro goats. 1. Coagulase activities and antibiotic susceptibility patterns.
    Adegoke GO
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):431-7. PubMed ID: 7198347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic markers of pediatric infections caused by coagulase-negative staphylococci.
    Dunne WM; Nelson DB; Chusid MJ
    Pediatr Infect Dis J; 1987 Nov; 6(11):1031-5. PubMed ID: 3696841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia.
    Ishak MA; Gröschel DH; Mandell GL; Wenzel RP
    J Clin Microbiol; 1985 Dec; 22(6):1025-9. PubMed ID: 4066912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulase negative Staphylococci as causative agents of urinary tract infections-prevalence and resistance status in IGIMS, Patna.
    Kumari N; Rai A; Jaiswal CP; Xess A; Shahi SK
    Indian J Pathol Microbiol; 2001 Oct; 44(4):415-9. PubMed ID: 12035353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance of coagulase-negative staphylococci from patients with urinary tract infection.
    Tokunaga S; Ohkawa M; Yamaguchi K; Nakashima T; Nishikawa T; Fujita S
    Int Urol Nephrol; 1993; 25(4):315-20. PubMed ID: 8276559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of factors associated with significant urinary tract infections caused by coagulase-negative staphylococci.
    Rimland D; Alexander W
    Diagn Microbiol Infect Dis; 1989; 12(2):123-7. PubMed ID: 2752711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coagulase-negative staphylococci in normal and chronically inflamed conjunctiva].
    Grasbon T; Miño de Kaspar H; Klauss V
    Ophthalmologe; 1995 Dec; 92(6):793-801. PubMed ID: 8563427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility to selected coagulase-negative chemotherapeutic agents of methicillin resistant staphylococci isolated from clinical materials in 1997-1998].
    Kochman M; Fordymacki P; Ławrynowicz-Paciorek M; Kałuzewski S; Meszaros J; Połowniak-Pracka H; Magdziak A; Sztandar-Sztanderska M
    Med Dosw Mikrobiol; 2000; 52(4):341-52. PubMed ID: 11286176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiograms and plasmids of Staphylococcus aureus and coagulase negative staphylococci isolated from different clinical sources.
    Obi CL; Iyiegbuniwe AE; Olukoya DK; Babalola C; Igumbor EO; Okonta AA
    Cent Afr J Med; 1996 Sep; 42(9):258-61. PubMed ID: 8997818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial sensivity and ability to slime production of koagulaze-negative staphylococci].
    Szczuka E; Prawda-Zołotar J; Nowakiewicz M; Kaznowski A
    Med Dosw Mikrobiol; 2011; 63(1):15-9. PubMed ID: 22184892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coagulase-negative staphylococci--biofilm and antibiotic resistance].
    Granslo H; Gammelsrud KW; Fredheim EA; Flaegstad T; Klingenberg C
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2746-9. PubMed ID: 19079425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant coagulase negative staphylococci from clinical samples.
    Goel MM; Singh AV; Mathur SK; Singh M; Singhal S; Chaturvedi UC
    Indian J Med Res; 1991 Nov; 93():350-2. PubMed ID: 1797641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivestigation of coagulase-negative staphylococci from infections in surgical patients.
    Marples RR; Hone R; Notley CM; Richardson JF; Crees-Morris JA
    Zentralbl Bakteriol Orig A; 1978 Jul; 241(1):140-56. PubMed ID: 696065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase produces dose-dependent decrease of slime production and adherence of slime-forming, coagulase-negative staphylococci.
    Sakarya S; Oncu S; Oncu S; Ozturk B; Tuncer G; Sari C
    Arch Med Res; 2004; 35(4):275-8. PubMed ID: 15325499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence of genus Staphylococcus. III. Studies on the pathogenicity to mice.
    Furusawa K; Miyoshi Y
    Bull Tokyo Med Dent Univ; 1975 Mar; 22(1):1-8. PubMed ID: 47790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulase-negative staphylococci: role as pathogens.
    Huebner J; Goldmann DA
    Annu Rev Med; 1999; 50():223-36. PubMed ID: 10073274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.